StockDuty ← Dashboard Oct 01, 2026 08:34 AM ET
SignalCorporate

CollPlant Biotechnologies GAAP EPS of -$0.87, revenue of $11.43M; reaffirms FY 2026 outlook

CollPlant's EPS miss and $11.43M revenue with reaffirmed FY 2026 outlook drive this alert.

CollPlant's EPS miss and $11.43M revenue with reaffirmed FY 2026 outlook drive this alert.
CollPlant's EPS miss and $11.43M revenue with reaffirmed FY 2026 outlook drive this alert. — impact context not separately stored; see What changed.
Sources